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ardiac
esynchronization Therapy 101
f It’s Not Late,
acing It Early Won’t Help*
nne B. Curtis, MD, FACC
ainesville, Florida
ardiac resynchronization therapy (CRT) is an effective
reatment for heart failure (HF) for patients who still have
ignificant symptoms despite optimal medical therapy.
any patients with HF have interventricular and intraven-
ricular conduction delays that cause delayed activation of
he lateral wall of the left ventricle (LV). This delayed
ctivation leads to ventricular dyssynchrony, which compro-
ises diastolic filling time, decreases LV ejection fraction,
nd worsens mitral regurgitation and ventricular dilation.
y placing a lead through the coronary sinus to a lateral or
osterolateral branch, the LV can be paced simultaneously
r near-simultaneously with pacing from the right ventricle,
eading to resynchronization of the ventricles. New York
eart Association functional class, exercise tolerance, qual-
ty of life, and LV ejection fraction have all been shown to
mprove with CRT (1–4).
See page 65
Although a consistent finding in these trials has been that
he majority of patients improve, there is still a substantial
inority who do not show any significant improvement
ither in symptoms or objective indexes of ventricular
unction after CRT. Placement of a lead to pace the LV can
e technically challenging, potentially leading to long pro-
edures in sick patients with advanced HF. Indeed, when
ransvenous lead placement fails, consideration is often
iven to epicardial lead placement, with its attendant
urgical morbidity. Thus, identification of patients who are
ighly unlikely to benefit from CRT would be helpful so
hat implantation can be avoided and alternative treatments
ecommended.
Why is it that some patients do not improve while
ndergoing CRT? In some patients it is not possible to
lace a lead in an appropriate venous branch, either because
f unfavorable anatomy or problems such as diaphragmatic
timulation or high pacing thresholds. In patients with
schemic cardiomyopathy, who are known to have a lower
uccess rate from CRT than patients with non-ischemic
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.f
From the Division of Cardiovascular Diseases, Department of Medicine, Univer-
ity of Florida, Gainesville, Florida.ardiomyopathy, there may be large akinetic areas along the
ateral wall from a previous myocardial infarction, leading to
neffective pacing (5,6). However, even patients with elec-
rocardiographic conduction delays and non-ischemic car-
iomyopathy do not always show improvement with CRT.
ow can we explain this observation?
All the major clinical trials of CRT used prolonged QRS
uration on the surface electrocardiogram as a major entry
riterion and marker for dyssynchrony. However, it has
ecome clear that wide QRS duration alone does not assure
hat ventricular dyssynchrony is present. Recent studies
sing a variety of echocardiographic techniques have shown
hat ventricular dyssynchrony can be quantified and that
ome patients with HF have dyssynchrony despite normal
RS durations (7).
A recent state-of-the-art paper published in the Journal
8) provided an excellent review of the echocardiographic
echniques currently available for evaluating ventricular
yssynchrony. Two types of ventricular dyssynchrony have
een described: interventricular dyssynchrony, which is the
elay in activation of the LV compared with the right
entricle; and intraventricular dyssynchrony, which is a
easure of the delayed activation of the lateral or posterior
alls of the LV compared with the septum. One simple
echnique using standard two-dimensional Doppler echo-
ardiography involves determining interventricular delay by
he difference in timing from the onset of the QRS to peak
ortic flow (Q-Ao) versus peak pulmonic flow, whereas
ntraventricular dyssynchrony is measured by evaluating the
iming difference between maximal systolic contraction of
he septum compared with the posterior LV wall by
-mode (9). Despite the simplicity of this approach,
dequate images to make these measurements cannot be
btained in all patients, thus leading to interest in other
echniques such as tissue Doppler imaging or three-
imensional echocardiography to evaluate delays in LV
ctivation (10–12). However, there is still no consensus as
o which parameter(s) should be measured to assess ventric-
lar dyssynchrony or what values best predict response to
RT.
In this issue of the Journal, Pitzalis et al. (13) studied the
orrelation of septal to posterior wall motion delay (SP-
MD) with outcomes from CRT. The investigators had
reviously reported that the presence of such a delay
orrelated with reverse remodeling after CRT, and that this
arameter was significantly better at predicting response to
RT than QRS duration, LV electromechanical delay
Q-Ao), or interventricular delay (9). In the current study,
0 patients with severe HF and left bundle-branch block
nderwent standard Doppler echocardiography that in-
luded assessment of SPWMD. Prolonged SPWMD, de-
ned as 130 ms, correlated significantly with a reduced
isk of HF progression and an improvement in LV ejection
raction.
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January 4, 2005:70–1 Editorial CommentDoes the study by Pitzalis et al. (13) provide the answer
s to a useful predictor of response to CRT? Unfortunately,
e are not there yet. An advantage to the investigators’
pproach is that a simple echocardiographic technique was
sed to make the determination of dyssynchrony. For
atients with adequate echocardiographic windows, includ-
ng all but three of the eligible patients in the Pitzalis et al.
13) study, the timing differences that indicate dyssynchrony
re simple enough to determine that other techniques, such
s tissue Doppler imaging, that may be less readily available
hould not be necessary. However, although the investiga-
ors found that a cutoff value of 130 ms for SPWMD was
redictive of response, SPWMD is a continuous variable
ith responders and non-responders found with values
bove and below the cutoff value. Thus, although the shorter
he SPWMD, the less likely the response to CRT, it is
nknown what values make a response unlikely enough to
void pursuing this therapeutic option. Despite this short-
oming, the study does indicate that, although QRS dura-
ion was one of the primary inclusion criteria used in the
ajor clinical trials of CRT, QRS duration alone is a poor
redictor of likely response to CRT.
For electrophysiologists who perform CRT procedures
nd for HF specialists who wish to refer appropriate patients
or this therapy, a simple and reliable technique is needed to
etermine whether ventricular dyssynchrony is present. It is
ot yet clear which parameter best indicates dyssynchrony
nd the likelihood of benefit from CRT: is it intraventric-
lar dyssynchrony alone, interventricular dyssynchrony
lone, or do both need to be present to make response
ikely? Is two-dimensional Doppler echocardiography suffi-
ient to make these determinations, or are other techniques
uch as tissue Doppler imaging necessary? Even if we know
hich parameter is best, it is unclear what values best
iscriminate patients likely and unlikely to benefit. Finally,
t would be most helpful to define when dyssynchrony is
inimal or absent so that CRT will not be offered to a
atient with HF who is highly unlikely to benefit. Whereas
t is clear that if it (the lateral wall) is not late then you
annot make it early by pacing, the definition of “late” still
eeds work.eprint requests and correspondence: Dr. Anne B. Curtis,
niversity of Florida, 1600 S.W. Archer Road, Box 100277,
ainesville, Florida 32610. E-mail: curtisa@medicine.ufl.edu.
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